Pharmacists Could Enhance Asthma And COPD Care
Main Category: Respiratory / AsthmaAlso Included In: COPD; Respiratory / Asthma; Pharmacy / Pharmacist
Article Date: 07 Sep 2009 - 2:00 PDT
| Patient / Public: | ![]() |
4 (3 votes) |
| Healthcare Prof: | ![]() |
1 (1 votes) |
| Article Opinions: | 1 posts |
Pharmacists are being urged to identify and refer patients with chronic lung and other conditions who have problems with their medication, following research showing that two thirds of asthma and COPD patients are under-using preventer inhalers and risking unnecessary breathing problems.
The research, discussed at the Royal Pharmaceutical Society's annual event, the British Pharmaceutical Conference in Manchester, showed that 64% of patients with asthma or COPD in a Cheshire PCT were under-using their preventer inhalers. They made them last days or weeks longer than would be expected if they were using them correctly.
This meant that the patients, who live in a part of the country with the highest asthma-related hospital admission rate in the UK, were missing out on essential corticosteroid drugs which form the backbone of preventive treatment for asthma and COPD. It is estimated that poorly controlled asthma costs the NHS £900m every year1.
"Maximum benefit from these important medicines is only achieved by regular use, even when patients are symptom free. The fact that so many patients aren't using their preventer inhalers means that we must look for new ways to identify those who need extra help with their medicines," explained Dr Ian Cubbin, of Liverpool John Moores University.
He suggested that pharmacists could play an important role in monitoring repeat prescriptions and referring patients who are under-using medication, as well as advising on good technique when using an inhaler:
"Patients with chronic diseases, such as asthma and COPD, see their community pharmacist more often than their GP. Through clinical medication reviews, pharmacists can help or refer patients who are having problems with their medicines before these become more serious, and thus help to reduce hospital admissions," he added.
Notes
The study was called An investigation into how poor compliance traditionally associated with corticosteroid therapy in asthma and chronic obstructive pulmonary disease can be improved to enhance long-term management and patient care. Authors: E. Marsden, I Cubbin and A McAlavey. It involved patients in the former Ellesmere Port and Neston Primary Care Trust. A total of 2, 340 patients with a diagnosis of either asthma or COPD were included in the study. Of these, 64% were under-using their corticosteroid inhaler and therefore receiving the drug at sub-therapeutic levels. A further 3% were over-using their inhaler and the remaining 33% were found to be compliant.
About asthma
5.4 million people currently receive treatment for asthma in the UK, and there are over 80,000 asthma-related admissions to hospital each year1. At least 75% of these admissions could be prevented with appropriate primary care management1.
About COPD
Chronic obstructive pulmonary disease (COPD) is an umbrella term for chronic bronchitis, emphysema and other lung diseases which result in damage to the airways, making it hard to breathe normally. An estimated 3 million people in the UK have COPD2, although many remain undiagnosed.
References
1. Asthma UK. Where do we stand? December 2004
2. Stang P, Lydick E, Silberman C et al. The Prevalence of COPD: Using smoking rates to estimate disease frequency in the general population. Chest 2000; 117: 354S-359S
The British Pharmaceutical Conference is the flagship annual conference of the RPSGB and is now in its 147th year. This year, it takes place in Manchester from Sunday 6 September - Wednesday 9 September inclusive. Around 1000 pharmacists from the UK and internationally will convene to debate practice issues and scientific developments affecting the profession during the four-day event.
Research released at BPC is published in the Journal of Pharmacy and Pharmacology.
Source
Royal Pharmaceutical Society of Great Britain
Visit our respiratory / asthma section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/163138.php>
APA
http://www.medicalnewstoday.com/releases/163138.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Patients Increasingly Forced To Use Mail Order Rx
posted by Anon on 7 Sep 2009 at 5:07 pmIn the US at least, the friendly neighborhood pharmacies are NOT allowed to be the pharmacy preferred by insurers. More and more are required to get their maintenance medications from mail order anonymous places where there is little or no interaction between patient and anyone (other than a machine who collects billing and shipping info).
Ideally, yes, pharmacists are a very important partner in chronic disease care. As a practical matter, in the US, this is becoming a less and less of a reality. Fortunately, most pharmacies still allow the public to speak with a pharmacist, whether or not they are present to pick up a prescription at no additional charge, but not sure how much longer that will continue either.
Anon
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





